Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

NCT03485976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Pityriasis Rubra Pilaris

Interventions

DRUG: Ixekizumab

Sponsor

Oregon Health and Science University

Collaborators

[object Object]